The impact of ischemia/reperfusion injury on specific and non-specific, early and late chronic events after organ transplantation

Transplantation Reviews

Volumn 10, Issue 4, 1996, Pages 236-253

  Land, W ^a,b   Messmer, K ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000508256     PISSN: 0955470X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-470X(96)80010-3     Document Type: Article

References (130)

1. Land W, Meßmer K: The impact of ischemia/reperfusion injury on specific and non-specific, early and late chronic events after organ transplantation. Early events. Transpl Rev 1996, 10:108
2. Tilney NL, Whitely WD, Diamond JR, et al: Chronic rejection - an undefined conundrum. Transplantation 1991, 52: 389
3. Paul LC, Fellström B: Chronic vascular rejection of the heart and the kidney - have rational treatment options emerged? Transplantation 1992, 53:1169
4. Häyry P, Isoniemi H, Yilmaz S, et al: Chronic allograft rejection. Immunol Rev 1993, 134:33
5. Paul LC: Functional and histological characteristics of chronic renal allograft rejection. Clin Transplantation 1991, 8:319
6. Matas A: Chronic rejection in renal transplant recipients - risk factors and correlates. Clin Transpl 1994, 8:332
7. Sibley RK: Morphologic features of chronic rejection in kidney and less commonly transplanted organs. Clin Transpl 1991, 8:293
8. Land W: Chronisches Transplantatversagen: - wie ist die Transplantatarteriosklerose zu verhüten? Therapiewoche 1995, 34:1982
9. ..tiopathogenese unter spezieller Berücksichtigung immunologischer Faktoren. Münchn Med Wschr 1996, 138:119
10. Land W, Schneeberger H, Schleibner S, et al: The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation 1991, 57:211
11. Troppmann Ch, Gillingham KJ, Benedetti E, et al: Delayed graft function, acute rejection, and outcome after cadaveric renal transplantation. A multivariate analysis. Transplantation 1995, 59:962
12. Terasaki PI, Cecka JH, Gjertson DW, et al: High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995, 333:333
13. Opelz G, Wujciak T, Mytilineos J, et al: Revisiting HLA matching for kidney transplantation. Transpl Proc 1993, 173
14. Halliwell B: Oxidants and human disease: some new concepts. FASEB J 1987, 1:358
15. (Black Circle sign)-derived from stimulated polymorphonuclear leukocytes. Possible mechanism in inflammation disease. J Clin Invest 1984, 73:1576
16. Ames BN: Oxidative DNA damage, cancer, and aging. Cross CE: moderator. Oxygen radicals and human disease. Ann Intern Med 1989;p 7:121
17. Woodruff T, Blake DR, Freeman J, et al: Is chronic synovitis an example of reperfusion injury; Ann Rheum Dis 1986, 45:608
18. Halliwell B: Proceedings of the Upjohn symposium on oxidants and disease. Bethesda, Federation of American Societies for Experimental Biology, 1987, 1988
19. Halliwell B: Current status review: free radicals, reactive oxygen species and human disease: a critical evaluation with special reference to atherosclerosis. Br J Exp Path 1989, 70:737
20. Silverman DJ, Santucci LA: Potential for free radical-induced lipid peroxidation as a cause of endothelial cell injury in rocky mountain spotted fever. Infect Immunol 1988, 56:3110
21. Whorton AR, Montgomery ME, Kent RS: Effect of hydrogen peroxide on prostagladin production and cellular integrity in cultured porcine aortic endothelial cells. J Clin Invest 1985, 76:295
22. Fridovich I: Superoxide dismutases. Adv Enzymol 1974, 41:35
23. Kukreja RC, Hess ML: The oxygen free radical system: from equations through membrane - protein interactions to cardiovascular injury and protection. Cardiovasc Res 1992, 26:641
24. Halliwell B, Gutteridge JMC: Free radicals in biology and medicine. Oxford: Clarendon Press 1985.
25. Carew TE, Schwenke DC, Steinberg D: Antiatherogenic effect of probucol unrelated to its hypo-cholesterolaemic effect: evidence that antioxidants in vivo can selectively inhibit LDL degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc Nat Acad Sci USA 1987, 84:7725
26. Bernheimer AW, Robinson WG, Linder R, et al: Toxicity of enzymically-oxidized low-density lipoprotein. Biochem Biophys Res Commun 1987; 148:260
27. Prasad K, Kalra J: Experimental atherosclerosis and oxygen free radicals. Angiology 1989, 40:835
28. Wilson RB: Lipid peroxidation and atherosclerosis. CRC Crit Rev Food Sci Nutr 1976, 8:325
29. Wolff SP, Dean RT: Glucose autoxidation and protein modification. The potential role of "autoxidative glycosylation" in diabetes. Biochem 1987, 245:243
30. Steinberg D, Parthasarathy S, Carew TE, et al: Beyond cholesterol. Modifications of low-density lipoprotein that increases its atherogenicity. N Eng J Med 1989, 320:915
31. French JE: Atherosclerosis in relation to the structure and function of the arterial intima, with special reference to the endothelium. Int Rev Expl Path 1966, 5:253
32. Mustard JF, Packham MA: The role of blood and platelets in atherosclerosis and the complication of atherosclerosis. Thromb Diath Haemorrh 1975; 33:444-456
33. Ross R, Glomset JA: Atherosclerosis and the arterial smooth muscle cell. Science 1973, 180:1332-1339
34. Virchow R: Gesammelte Abhandlungen zur Wissenschaftl. Medizin. Verlag Meidinger, Sohn, Berlin 1856, p 458
35. Ross R, Glomset JA: N Engl J Med 1976, 295:369
36. Ross R, Harker L: Hyperlipidemia and atherosclerosis: Chronic hyperlipidemia initiates and maintains lesions by endothelial cell desquamation and lipid accumulation. Science 1976, 193:1091-1100
37. Ross R: Atheriosclerosis: A problem of the biology of arterial wall cells and their interactions with blood components. Arteriosclerosis 1981, 1:293
38. Ross R: The pathogenesis of atherosclerosis - an update. N Engl J Med 1986, 314:488
39. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801
40. Steinbrecher UP, Zhang HF, Lougheed M: Role of oxidatively modified LDL in atherosclerosis. Free Radical Biol Med 1990, 9:155
41. Steinberg D: Antioxidants and atherosclerosis. A current assessment. Circulation 1991, 84:1420
42. Masuda J, Ross R: Atherogenesis during low level hypercholesterolemia in the nonhuman primate. I. Fatty streak formation. II. Fatty streak conversion to fibrous plaque. Arteriosclerosis 1990, 10:164
43. Rosenfeld ME, Tsukada T, Chait A, Bierman EL, Gown AM, Ross R: Fatty streak expansion and maturation in Watanaba heritable hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis 1987, 7:24
44. Mora R, Lupu F, Simionescu N: Prelesional events in atherogenesis: Colocalization of apolipoprotein B, unesterified cholesterol and extracellular phospholipid liposomes in the aorta of hyperlipidemic rabbit. Atheriosclerosis 1987, 67:143
45. Tsukada T, Rosenfeld ME, Ross R, et al: Immunocy tochemical analysis of cellular components in atheriosclerotic lesions. Use of monoclonal antibodies with the Watanaba and fat-fed rabbit. Arterisclerosis 1986, 6:601
46. Davies MJ, Woolf N, Rowles PM, et al: Morphology of the endothelium over atherosclerotic plaques in human coronary arteries. Br Heart J 1988, 60:459
47. Hart CE, Forstrom JW, Kelly JD, et al: Two classes of PDGF receptor recognize different isoforms of PDGF. Science 1988, 240:1529
48. Heldin CH, Westermark B: Platelet-derived growth factor: mechanism of action and possible in vivo function. Cell Reg 1990, 1:555
49. Banskota NK, Taub R, Zellner K, et al: Insulin, insulin-like growth factor 1 and platelet-derived growth factor interact additively in the induction of the protooncogene c myc and cellular proliferation in cultured bovine aortic smooth muscle cells. Molec Endocrinol 1989, 3:1183
50. Libby P, Warner SJ, Friedman GB: Interleukin-1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J Clin Invest 1988, 81:487
51. Old LJ: Tumor necrosis factor (TNF). Science 1985, 230:630
52. Häyry P, Yilmaz S: Role of growth factors in graft vessel disease. Transplant Proc 1995, 27:2066
53. Ylä-Herttuala S, Lipton BA, Rosenfeld ME, et al: Expression of monocyte chemoattractant protein 1 in macrophage - rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 1991, 88:5252
54. Ferns GA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R: Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 1991, 253:1129
55. Springer TA: Adhesion receptors of the immune system. Nature 1990, 346:425
56. Cybulsky M, Gimbrone MA Jr: Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991, 251:788
57. Carlos TM, Harlan JM: Membrane proteins involved in phagocyte adherence to endothelium. Immun Rev 1990, 114:5
58. Goldstein JL, Ho YK, Basu SK, Brown MS: Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 1979, 76:333
59. Parthasarathy S, Wicland E, Steinberg D: A role for endothelial cell lipooxygenase in the oxidative modification of low density lipoprotein. Proc Natl Acad Sci USA 1989, 86:1016
60. Zweier JL, Broderick R, Kuppusamy P, et al: Determination of the mechanism of free radical generation in human aortic endothelial cells exposed to anoxia and reoxygenation. J Biol Chem 1994, 269:24156
61. Zweier JL, Kuppusamy P, Thompson-Gorman S, et al: Measurement and characterization of free radical generation in reoxygenated human endothelial cells. Amer J Physiol 1991, 266:C700
62. McCord JM: Oxygen-derived free radicals in post ischemic tissue injury. N Engl J Med 1985, 312:159
63. Akyürek ML, Funa K, Wanders A, et al: Expression of CD 11 b and ICAM-1 in an in vivo model of transplant arteriosclerosis. Transpl Immunol 1995, 3:107
64. Gohra H, McDonald TO, Verrier ED, et al: Endothelial loss and regeneration in a model of transplant arteriosclerosis. Transplantation 1995, 60:96
65. Wanders A, Akyürek ML, Waltenberger J, et al: Ischemia-induced transplant arteriosclerosis in the rat. Artcroscler Thromb Vasc Biol 1995, 15:145
66. Wanders A, Waltenberger J: Transplantation models of accelerated arteriosclerosis and their use for morphological and molecular analysis
67. Akyürek ML, Wanders A, Aurivillius M, Larsson E, Funa K, Fellström BC: Effects of angiopeptin on transplant arteriosclerosis in the rat. Transpl Int 1995, 8:103
68. Yilmaz S, Paavonen T, Häyry P: Chronic rejection of rat kidney allografts. II. The impact of prolonged ischemia on transplant histology. Transplantation 1992, 53:823
69. Yilmaz A, Yilmaz S, Kallio E, Rapola J, Häyry P: Evolution of glomerular basement membrane changes in chronic rejection. Transplantation 1996 (in press)
70. Myllärniemi M, Rälsänen-Sokolowski A, Vuoristo P, et al: Lack of effect of recombinant human superoxide dismutase on cold ischemia-induced arteriosclerosis in syngeric rat aortic transplants. Transplantation 1996, 61:1018
71. Schmid C, Heemann UW, Azuma H, Tilney NL: Transplant vasculopathy in rat heart transplantation: a morphologic Chameleon determined by antigen-dependent and - independent factors. Transplant Proc 1995, 27:2077
72. Tullius SG, Heemann UW, Hancock WW, et al: Long-term kidney isografts develop functional and morphologic changes that mimic those of chronic allograft rejection. Ann Surg 1994, 220:425
73. Tilney NL: Renal transplantation between identical twins: a review. World J Surg 1986, 10:381
74. Glassock RJ, Feldman D, Reynolds EG, et al: Human renal isografts: a clinical and pathological analysis. Medicine 1968, 47:411
75. Dammin GJ: Renal transplants: correlations of histological patterns with function in the kidney, in: Mostofi FK, Smith DE (eds). The kidney. Baltimore, Williams and Wilkins, 1966, p 445
76. Hostetter TH, Olson JL, Rennke HG, et al: Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 1981, 241:F85
77. Brenner BM: Hemodynamically mediated glomerular injury and the progressive nature of glomerular disease. Kidney Int 1983, 23:617
78. Heemann UW, Azuma H, Tullius SG, et al: The contribution of reduced functioning mass to chronic kidney allograft dysfunction in rats. Transplantation 1991, 58:1317
79. Land W, Schleibner S, Hillebrand G, et al: Long-term results under Ciclosporine therapy in cadaveric renal transplantation. XII. Int. Congr. The Transplantation Soc San Francisco 1990 Symposium and Poster Abstracts, p 110
80. Land W, Schneeberger H, Schleibncr S, et al: Long-term results in cadaveric renal transplantation under Ciclosporine therapy. Transplant Proc 1991, 23:1244
81. Tesi RU, Henry ML, Elkhammas EA, et al: Predictors of long-term primary cadaveric renal transplant survival. Clin Transpl 1993, 7:343
82. Almond PS, Matas AJ, Gillingham K, et al: Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993, 55:752
83. Lindholm A, Ohlman S, Albrechtsen D, et al: The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplants treated by 3 Ciclosporine regimens. Transplantation 1993, 56:307
84. Isoniemi H, Nurminen M, Tikkanen MJ, et al: Risk factors predicting chronic rejection of renal allografts. Transplantation 1994, 57:68
85. Yilmaz S, and Häyry P: The impact of acute episodes of rejection on the generation of chronic rejection in rat renal allografts. Transplantation 1993, 56:1153
86. Solez K: International standardization of criteria for histological diagnosis of chronic rejection in renal allografts. Clin Transpl 1994, 8:345
87. Salom R, Maguire J, Esmore, Hancock W: Endothelial cell activation and cytokine expression during acute human cardiac allograft rejection. Transplant Proc 1995, 27:2161
88. Orosz CG: Endothelial activation and chronic allograft rejection. Clin Transpl 1991, 8:299
89. Heemann UW, Tullius SG, Azuma H, et al: Adhesion molecules and transplantation. Ann Surg 1994, 219:4
90. Fuggle S, Sanderson JB, Gray DWR, et al: Variation in expression of endothelial adhesion molecules in pretransplant and transplanted kidneys - correlation with intragraft events. Transplantation 1993, 55:117
91. Opelz G, Wujciak T for the Collaborative Transplant Study: Comparative analysis of kidney preservation methods. Transpl Proc 1996, 28:87
92. Gerston DW: Short- and long-term effects of HLA matching. Clin Transpl 1989, p 353
93. Petersen P, Schneeberger H, Schleibncr S, Illner WD, Hofmann GO, Scholz S, Albert ED, Land W: HLA matching and short/longterm outcome of cadaveric renal allografts: large single-centre data confirm the multicentre analyses. Transpl Proc 1995, 27:651
94. Land W: Unpublished observation
95. Ferguson RM: Acute rejection episodes. Best predictor of long-term primary cadaveric renal transplant survival. Clin Transplantation 1991, 8:328
96. Paul LC: Experimental models of chronic renal allograft rejection. Transpl Proc 1995, 27:2126
97. Heemann UW, Tullius SG, Tamatami T, et al: Infiltration pattern of macrophages and lymphocytes in chronically rejecting rat kidney allografts. Transplant Int 1994, 7:349
98. Schmid C, Heemann UW, Tilney NL: Die chronische Abstoßung des Herzens im Rattenmodell. - Ent-wicklung der Transplantatvaskulopathie, zelluläre Infiltration und Expression der Zelloberflächenmole-küle. Z. Herz-, Thorax-Gefäßchir. 1995, 9:164
99. Diamond JR, Tilney NL, Frye J et al: Progressive albuminuria and glomerulosclerosis in a rat model of chronic renal allograft rejection. Transplantation 1992, 54:710
100. Azuma H, Heemann UW, Tullius SG, Tilney NL: Cytokines and adhesion molecules in chronic rejection. Clin Transpl 1994, 8:168
101. Tilney NL: Thoughts on the immunobiology of chronic allograft rejection. Transpl Proc 1995, 27:2123
102. Fellström BC, Akjürek L, Dimény EM, et al: J Chronic vascular rejection (CVR). Mitt Klin Nephralgie 1995, 24:41
103. Waltenberger J, Wanders A, Fellström BC, et al: Induction of transforming growth factor-β during cardiac allograft rejection. J Immunol 1993, 151:1147
104. Waltenberger J, Akjürck ML, Aurivillius M, et al: Ischemia-induced transplant arteriosclerosis in the rat. Induction of peptide growth factor expression. Arterioscler Thromb Vasc Biol 1996, 15:145
105. Libby P, Tanaka H: The pathogenesis of coronary arteriosclerosis (chronic rejection) in transplanted hearts. Clin Tranpl 1994, 8:313
106. Karnovsky MJ, Russell ME, Hancock W, et al: Chronic rejection in experimental cardiac transplantation in a rat model. Clin Transpl 1991, 8:308
107. Fellström BC: Immune injury - is it all there is to chronic graft rejection? Nephrol Dial Transplant 1995, editorial, comments p 149
108. Helderman JH, van Buren DH, Amend WJC, et al: Chronic immunosuppression of the renal transplant patient. J Am Soc Nephrol 1991, 4:52 (suppl 1)
109. Kuo I, Monaco AP: Chronic rejection as a result of suboptimal immunosuppression. Transpl Proc 1993, 25:2082
110. Ponticelli C, Minetti L, Di Palo FW, et al: The Milan clinical trial with Ciclosporine in cadaveric renal transplantation. A three year follow-up. Transplantation 1988, 45:908
111. th Congress of the Asian Society of Transplantation, August 1995, Seoul, Korea, Abstract Vol, p 14
112. Andersen HO, Holm P, Slender S, et al: Relative importance of ischemic injury and immunologic injury in the development of transplant arteriosclerosis in rabbit aortic allografts. Transplantation 1995, 60:631
113. Tullius SG, Hancock WW, Heemann UW, et al: Reversibility of chronic renal allograft rejection. Transplantation 1994, 58:93
114. Izutani H, Miyagawa S, Shirakura R, et al: Evidence that graft coronary arteriosclerosis begins in the early phase after transplantation and progresses without chronic immunoreaction. Transplantation 1995, 60:1073
115. Battegay EJ, Raines EW, Seifert RA, et al: TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell 1990, 63:515
116. Libby P, Warner SJC, Salomon RN, Birinyi LK: Production of platelet-derived growth factor-like mitogen by smooth-muscle cells from human atheroma. N Engl J Med 1988, 318:1493
117. Wilcox JN, Smith KM, Williams LT, et al: Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J Clin Invest 1988, 82:1134
118. Ross R, Masuda J, Raines EW, et al: Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science 1990, 248:1009
119. Raines EW, Dower SK, Ross R: Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science 1989, 243:393
120. Hajjar KA, Hajjar DP, Silverstein RL, Nachman RL: Tumor necrosis factor-mediated release of platelet-derived growth factor from cultured endothelial cells. J Exp Med 1987, 166:235
121. Ruscetti FW, Palladino MA: Transforming growth factor-beta and the immune system. Prog Growth Factor Res 1991, 3:159
122. Fellström BC, Akyürek ML, Dimény EM, et al: Nonimmunologic factors involved in long-term renal allograft deterioration. Advances in Nephrology 1996, 25:51
123. Rosenfeld ME, Ross R: Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis 1990, 10:680
124. Gordon D, Reidy MA, Benditt EP, Schwartz SM: Cell proliferation in human coronary arteries. Proc Natl Acad Sci USA 1990, 87:4600
125. Rosenfeld ME, Ylä-Herttuala S, Lipton BA, et al: Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans. Amer J Path 1992, 140:291
126. Libby P, Tanaka H, Swanson SJ, et al: The role of cytokines in graft vessel disease after cardiac transplantation. Transpl Proc 1995, 27:2062
127. Shimokado K, Raines EW, Madtes DK, et al: A significant part of macrophage-derived growth factor consists of at least two forms of PDGF. Cell 1985, 43:277
128. Libby P, Ordovas JM, Auger KR, et al: Endotoxin and tumor necrosis factor induce interleukin-1-gene expression in adult human vascular endothelial cells. Amer J Path 1986, 124:179
129. Libby P, Friedman GB, Salomon RN: Cytokines as modulators of cell proliferation in fibrotic diseases. Amer Rev Resp Dis 1989, 140:1114
130. Land W, Schneeberger H, Hillebrand S, et al: Unspecific primary ischemia reperfusion injury in combination with secondary specific acute rejection-mediated injury of kidney allografts contributes mainly to development of chronic transplant failure. XVI